{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:57:49Z","timestamp":1790780269308,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-2010-BLAN-1405 01"],"award-info":[{"award-number":["ANR-2010-BLAN-1405 01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.coph.2014.11.008","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T11:17:31Z","timestamp":1418296651000},"page":"73-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"special_numbering":"C","title":["NMDA receptor subunit mutations in neurodevelopmental disorders"],"prefix":"10.1016","volume":"20","author":[{"given":"Nail","family":"Burnashev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Szepetowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2014.11.008_bib0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.coph.2014.11.008_sbref0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.coph.2014.11.008_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coph.2006.08.011","article-title":"NMDA receptor subunits: function and pharmacology","volume":"7","author":"Paoletti","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coph.2014.11.008_bib0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/mol.113.085803","article-title":"Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-d-aspartate receptors","volume":"84","author":"Hansen","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2014.11.008_bib0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nature07993","article-title":"Mechanism of differential control of NMDA receptor activity by NR2 subunits","volume":"459","author":"Gielen","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.coph.2014.11.008_bib0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/mol.110.067157","article-title":"Control of assembly and function of glutamate receptors by the amino-terminal domain","volume":"78","author":"Hansen","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2014.11.008_bib0035","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.1523\/JNEUROSCI.1365-09.2009","article-title":"Control of NMDA receptor function by the NR2 subunit amino-terminal domain","volume":"29","author":"Yuan","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2014.11.008_bib0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2012.12.003","article-title":"Activation of extrasynaptic NMDA receptors induces LTD in rat hippocampal CA1 neurons","volume":"93","author":"Liu","year":"2013","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.coph.2014.11.008_bib0045","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ana.23626","article-title":"Activation of microglial N-methyl-d-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain","volume":"72","author":"Kaindl","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coph.2014.11.008_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.01.004","article-title":"Influence of the NR3A subunit on NMDA receptor functions","volume":"91","author":"Henson","year":"2010","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.coph.2014.11.008_bib0055","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1113\/jphysiol.2010.195503","article-title":"The receptor subunits generating NMDA receptor mediated currents in oligodendrocytes","volume":"588","author":"Burzomato","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.coph.2014.11.008_bib0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajhg.2011.02.001","article-title":"Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability","volume":"88","author":"Hamdan","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coph.2014.11.008_sbref0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12439","article-title":"De novo mutations in epileptic encephalopathies","volume":"501","author":"Epi4K Consortium","year":"2013","journal-title":"Nature"},{"issue":"Suppl 7","key":"10.1016\/j.coph.2014.11.008_bib0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1528-1167.2009.02214.x","article-title":"From rolandic epilepsy to continuous spike-and-waves during sleep and Landau-Kleffner syndromes: insights into possible genetic factors","volume":"50","author":"Rudolf","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.coph.2014.11.008_sbref0075","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1528-1167.2012.03559.x","article-title":"Epileptic encephalopathies of the Landau-Kleffner and continuous spike and waves during slow-wave sleep types: genomic dissection makes the link with autism","volume":"53","author":"Lesca","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.coph.2014.11.008_sbref0080","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ng.2727","article-title":"GRIN2A mutations cause epilepsy-aphasia spectrum disorders","volume":"45","author":"Carvill","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2014.11.008_sbref0085","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ng.2728","article-title":"Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes","volume":"45","author":"Lemke","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2014.11.008_sbref0090","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.2726","article-title":"GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction","volume":"45","author":"Lesca","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2014.11.008_bib0095","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.pediatrneurol.2013.08.023","article-title":"Two patients with a GRIN2A mutation and childhood-onset epilepsy","volume":"49","author":"DeVries","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.coph.2014.11.008_bib0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/epi.12502","article-title":"A subset of genomic alterations detected in rolandic epilepsies contains candidate or known epilepsy genes including GRIN2A and PRRT2","volume":"55","author":"Dimassi","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.coph.2014.11.008_bib0105","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1528-1167.2010.02555.x","article-title":"Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region","volume":"51","author":"Reutlinger","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.coph.2014.11.008_bib0110","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1206524","article-title":"Diagnostic exome sequencing in persons with severe intellectual disability","volume":"367","author":"de Ligt","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2014.11.008_sbref0115","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1038\/ncomms4251","article-title":"Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy","volume":"5","author":"Yuan","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2014.11.008_bib0120","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ng.677","article-title":"Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes","volume":"42","author":"Endele","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2014.11.008_bib0125","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/epi.12663","article-title":"Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation","volume":"55","author":"Venkateswaran","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.coph.2014.11.008_bib0130","doi-asserted-by":"crossref","first-page":"e99294","DOI":"10.1371\/journal.pone.0099294","article-title":"Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson's disease in Swedish population","volume":"9","author":"Yamada-Fowler","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coph.2014.11.008_bib0135","doi-asserted-by":"crossref","first-page":"e1002237","DOI":"10.1371\/journal.pgen.1002237","article-title":"Genome-wide gene\u2013environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee","volume":"7","author":"Hamza","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.coph.2014.11.008_bib0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0165-3806(97)00148-X","article-title":"NMDA receptor antagonists influence early development of GABAergic interneurons in the mammalian striatum","volume":"105","author":"Sadikot","year":"1998","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.coph.2014.11.008_bib0145","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1523\/JNEUROSCI.4722-05.2006","article-title":"A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons","volume":"26","author":"Kinney","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2014.11.008_bib0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/acn3.39","article-title":"GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine","volume":"1","author":"Pierson","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.coph.2014.11.008_bib0155","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.1227764","article-title":"Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders","volume":"338","author":"O\u2019Roak","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coph.2014.11.008_sbref0160","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng.835","article-title":"Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations","volume":"43","author":"O\u2019Roak","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2014.11.008_bib0165","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/mp.2013.127","article-title":"Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders","volume":"19","author":"Kenny","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.coph.2014.11.008_bib0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cell.2012.03.028","article-title":"Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries","volume":"149","author":"Talkowski","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.coph.2014.11.008_bib0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.24073","article-title":"GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy","volume":"75","author":"Lemke","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coph.2014.11.008_bib0180","doi-asserted-by":"crossref","first-page":"e1001318","DOI":"10.1371\/journal.pgen.1001318","article-title":"A population genetic approach to mapping neurological disorder genes using deep resequencing","volume":"7","author":"Myers","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.coph.2014.11.008_bib0185","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1038\/tp.2011.52","article-title":"Rare mutations in N-methyl-d-aspartate glutamate receptors in autism spectrum disorders and schizophrenia","volume":"1","author":"Tarabeux","year":"2011","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.coph.2014.11.008_bib0190","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/epi.12645","article-title":"Towards the identification of a genetic basis for Landau-Kleffner syndrome","volume":"55","author":"Conroy","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.coph.2014.11.008_bib0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1744-9081-9-20","article-title":"Behavioral phenotype in five individuals with de novo mutations within the GRIN2B gene","volume":"9","author":"Freunscht","year":"2013","journal-title":"Behav Brain Funct"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489214001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489214001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T10:54:40Z","timestamp":1589280880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489214001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":39,"alternative-id":["S1471489214001635"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2014.11.008","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NMDA receptor subunit mutations in neurodevelopmental disorders","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2014.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}